Novo Nordisk Q3 Net Sales Rise; Raises 2026 Sales Guidance

04:26 AM EST, 11/04/2026 (MT Newswires) -- Novo Nordisk (NVO) reported Q3 net sales of 79.20 billion Danish kroner ($8.59 billion), compared with 74.98 billion kroner a year earlier. Analysts polled by FactSet expected 73.90 billion kroner. The company said it now expects 2026 adjusted sales of between -2% and 2% at constant exchange rates, compared with a 0% to 6% decline previously, driven by increased expectations for GLP-1 product sales. Analysts surveyed by FactSet expected 302.75 billion kroner. Separately, Novo Nordisk said its CFO, Karsten Munk Knudsen, will leave the company and Luigi La Corte will take over the role, according to a Reuters report.